Maker's videoMMI - Medical Microinstruments, Inc. · 26 Oct 2023
MicroChats: Changing Lives with Robotic Lymphatic Supermicrosurgery
Against the record
Symani, from MMI (Medical Microinstruments), is at stage 5 of 5 on our ladder: regulator-cleared or mass market. Cleared where approval applies, or widely sold. The latest milestone on its record is from 4 May 2026: Baptist Health in Jacksonville, Florida did the first operation in a US study (REMIND) testing Symani microsurgery for Alzheimer's and similar brain diseases. The study plans 15 patients.
This video comes from the maker's own channel, and makers show their robots at their best. The stage above comes from dated public records, not from the video.
From the video's description
Tune into this episode of MicroChats featuring Professor Sinikka Suominen and Professor Nicole Lindenblatt. They share insights into their extensive clinical experience with lymphatic microsurgery and keys to building a successful robotics program. Hear more about the benefits they have seen with using Symani in lymphatic surgery and their views on how new technology may impact the surgical treatment of lymphedema by offering a potential solution for patients suffering from the disease.
Written by MMI - Medical Microinstruments, Inc. on YouTube.
More videos of Symani
The Synaptix™ Digital Surgery Platform: Purpose-Built to Enhance Symani®
Robotic-assisted Lymphovenous Bypass for Breast Cancer Related Lymphedema│ A Symani® Patient Story
Symani® Workflow | Robotic-assisted Procedure set-up with the Symani Surgical System
Symani® Surgical System Product Video | Robotic System Overview
MicroChats: Why Robotics in Microsurgery Matters
Robotic-Assisted Breast Reconstruction with Symani | A Connecting the Dots Series Story